These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24438587)

  • 41. The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study.
    Jung IS; Kim HS; Park H; Lee SI
    J Clin Gastroenterol; 2009 Jul; 43(6):534-40. PubMed ID: 19262407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lactulose breath test results in patients with persistent abdominal symptoms following Giardia lamblia infection.
    Morken MH; Nysaeter G; Strand EA; Hausken T; Berstad A
    Scand J Gastroenterol; 2008; 43(2):141-5. PubMed ID: 17943632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sequelae of traveler's diarrhea: focus on postinfectious irritable bowel syndrome.
    Connor BA
    Clin Infect Dis; 2005 Dec; 41 Suppl 8():S577-86. PubMed ID: 16267722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Update on human Campylobacter jejuni infections.
    Kirkpatrick BD; Tribble DR
    Curr Opin Gastroenterol; 2011 Jan; 27(1):1-7. PubMed ID: 21124212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Irritable bowel syndrome in persons who acquired trichinellosis.
    Soyturk M; Akpinar H; Gurler O; Pozio E; Sari I; Akar S; Akarsu M; Birlik M; Onen F; Akkoc N
    Am J Gastroenterol; 2007 May; 102(5):1064-9. PubMed ID: 17313500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The clinical characteristics of postinfectious irritable bowel syndrome in Qingdao].
    Ju H; Liu XS; Wang GL; Zhang HY; Dai SM; Mao T
    Zhonghua Nei Ke Za Zhi; 2009 Jun; 48(6):473-5. PubMed ID: 19954042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postinfectious irritable bowel syndrome may occur after non-gastrointestinal and intestinal infection.
    McKeown ES; Parry SD; Stansfield R; Barton JR; Welfare MR
    Neurogastroenterol Motil; 2006 Sep; 18(9):839-43. PubMed ID: 16918763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disease burden of post-infectious irritable bowel syndrome in The Netherlands.
    Haagsma JA; Siersema PD; De Wit NJ; Havelaar AH
    Epidemiol Infect; 2010 Nov; 138(11):1650-6. PubMed ID: 20223049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenesis of irritable bowel syndrome--review regarding associated infection and immune activation.
    Ishihara S; Tada Y; Fukuba N; Oka A; Kusunoki R; Mishima Y; Oshima N; Moriyama I; Yuki T; Kawashima K; Kinoshita Y
    Digestion; 2013; 87(3):204-11. PubMed ID: 23712295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Post-infectious irritable bowel syndrome].
    Pallotti F; Fogacci E; Frisoni C; Serra M; Bellacosa L; Carini G; Cremon C; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
    Clin Ter; 2011; 162(2):157-61. PubMed ID: 21533323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Functional and inflammatory bowel disorders].
    Frieling T
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():139-42. PubMed ID: 16802539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The incidence and risk factors of post-infectious irritable bowel syndrome: a meta-analysis.
    Dai C; Jiang M
    Hepatogastroenterology; 2012; 59(113):67-72. PubMed ID: 22024145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective study evaluating immune-mediated mechanisms and predisposing factors underlying persistent postinfectious abdominal complaints.
    Florens MV; Van Wanrooy S; Dooley J; Aguilera-Lizarraga J; Vanbrabant W; Wouters MM; Van Oudenhove L; Peetermans WE; Liston A; Boeckxstaens GE
    Neurogastroenterol Motil; 2019 Apr; 31(4):e13542. PubMed ID: 30657233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postinfectious irritable bowel syndrome--a meta-analysis.
    Halvorson HA; Schlett CD; Riddle MS
    Am J Gastroenterol; 2006 Aug; 101(8):1894-9; quiz 1942. PubMed ID: 16928253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postinfectious irritable bowel syndrome.
    DuPont AW
    Clin Infect Dis; 2008 Feb; 46(4):594-9. PubMed ID: 18205536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα.
    Swan C; Duroudier NP; Campbell E; Zaitoun A; Hastings M; Dukes GE; Cox J; Kelly FM; Wilde J; Lennon MG; Neal KR; Whorwell PJ; Hall IP; Spiller RC
    Gut; 2013 Jul; 62(7):985-94. PubMed ID: 22684480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of functional gastrointestinal disorders after Giardia lamblia infection.
    Hanevik K; Dizdar V; Langeland N; Hausken T
    BMC Gastroenterol; 2009 Apr; 9():27. PubMed ID: 19383162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infectious causation of chronic disease: examining the relationship between Giardia lamblia infection and irritable bowel syndrome.
    Penrose AS; Wells EV; Aiello AE
    World J Gastroenterol; 2007 Sep; 13(34):4574-8. PubMed ID: 17729408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron.
    Dizdar V; Gilja OH; Hausken T
    Neurogastroenterol Motil; 2007 Dec; 19(12):977-82. PubMed ID: 17973637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Post-infectious irritable bowel syndrome--a review of the literature.
    Schwille-Kiuntke J; Frick JS; Zanger P; Enck P
    Z Gastroenterol; 2011 Aug; 49(8):997-1003. PubMed ID: 21811952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.